產(chǎn)品目錄

規(guī)格	5mg 25mg
CAS	1228013-30-6
別名
化學(xué)名	7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((1r,4r)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one
分子式	C21H27N5O3
分子量	397.47
溶解度	DMF: 30 mg/mL,DMF:PBS(pH 7.2)(1:1): 0.5 mg/mL,DMSO: 25 mg/mL,Ethanol: 20 mg/mL
儲(chǔ)存條件	Store at -20°C
General tips	For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition	Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request

產(chǎn)品描述：

CC-223 is an orally bioavailable mTOR inhibitor.

The mammalian target of rapamycin (mTOR) pathway is critical for tumor development, and mTOR inhibitors have revealed modest results.

In vitro: CC-223 was identified as an ATP–competitive inhibitor of the mTOR kinase targeting mTORC1 of both 4EBP1 and p70 S6 kinase 1 and mTORC2, which prevented the upregulation of AKT phosphorylation. Moreover, CC-223 was selectively potent to mTOR kinase while showed more than 150-fold sensitivity against the related lipid kinase, PI3Ka. In addition, CC-223 was active over many non-Hodgkin lymphoma cell lines and solid tumor lines such as including glioma, breast, hepatocellular carcinoma, as well as non–small cell lung cancer [1].

In vivo: In animal study, CC-223 was selected for evaluation in PC-3 tumor bearing efficacy mouse models. Mice were orally treated with vehicle or various doses of CC-223 once daily or twice daily at a dose of 5 mL/kg for 21 days, and the final reductions of tumor volume were measured following the final day of dosing. Results showed that All CC-223 had dose- and schedule-dependent inhibition of tumor growth in the PC-3 model. Moreover, the maximum observed efficacy for CC-223 was determined to be 87%, at its tolerated dose of 25 mg/kg q.d. [1].

Clinical trial: In previous clinical study, CC-223 was found to be tolerable with manageable toxicities. In addition, the preliminary antitumor activity, such as tumor regression and evidence of mTORC1/mTORC2 pathway inhibition were also observed [2].

References:

[1] Mortensen DS, et al. Discovery of Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor CC-223. J Med Chem. 2015 Jul 9;58(13):5323-5333.

[2] Bendell JC, et al. A phase I dose-escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC-223 in patients with advanced solid tumors or multiple myeloma. Cancer. 2015 Oct 1;121(19):3481-90.

特別提醒：

1. 本產(chǎn)品僅供科研使用。請(qǐng)勿用于醫(yī)藥、臨床診斷或治療，食品及化妝品等用途。請(qǐng)勿存放于普通住宅區(qū)。

2. 為了您的安全和健康，請(qǐng)穿好實(shí)驗(yàn)服并佩戴一次性手套和口罩操作。

原創(chuàng)作者：上海莼試生物技術(shù)有限公司

在線(xiàn)咨詢(xún)

留言注意事項(xiàng)：

1.遵守中華人民共和國(guó)有關(guān)法律、法規(guī)，尊重網(wǎng)上道德，承擔(dān)一切因您的行為而直接或間接引起的法律責(zé)任。

2.請(qǐng)您真實(shí)的反映產(chǎn)品的情況,不要捏造、誣蔑、造謠。如對(duì)產(chǎn)品有任何疑問(wèn),也可以留言咨詢(xún)。

3.未經(jīng)本站同意，任何人不得利用本留言簿發(fā)布個(gè)人或團(tuán)體的具有廣告性質(zhì)的信息或類(lèi)似言論。

您感興趣的產(chǎn)品*
您的單位*
聯(lián)系人*
聯(lián)系電話(huà)*
詳細(xì)地址*
常用郵箱*
請(qǐng)輸入您對(duì)我們的意見(jiàn)或建議*
驗(yàn)證碼*

同類(lèi)產(chǎn)品

Sulfasalazine SD 1029 Vanoxonin Neriifolin Termitomycamide B nor-NOHA (acetate) Naphthazarin Tetrahydroxyquinone monohydrate Taurochenodeoxycholic Acid (sodium salt) apimod tetrahydrochloride

訂購(gòu)流程

訂貨流程

產(chǎn)品訂購(gòu)說(shuō)明:

1、報(bào)價(jià)含普票、運(yùn)費(fèi)。

2、常用試劑備貨充足，除對(duì)溫度要求極其嚴(yán)格的產(chǎn)品當(dāng)天可發(fā)貨。

3、進(jìn)口原裝產(chǎn)品要3-6周的貨期，詳細(xì)情況請(qǐng)咨詢(xún)客服。

4、訂貨時(shí)間為工作日每周一至周五16:00之前。

5、如需代為檢測(cè)，標(biāo)本對(duì)環(huán)境溫度高，可聯(lián)系客服安排專(zhuān)人取樣（限省內(nèi)客戶(hù)）。

6、代測(cè)免收代測(cè)費(fèi)，一周出結(jié)果。

7、產(chǎn)品因運(yùn)輸途中包裝破損請(qǐng)拒絕簽收，做退回。我們將在24小時(shí)之內(nèi)為您補(bǔ)發(fā) 損壞產(chǎn)品。

8、如因單位財(cái)務(wù)制度原因，可申請(qǐng)先發(fā)貨，報(bào)賬后付款（此條款僅限醫(yī)院、學(xué)校信譽(yù)良好客戶(hù)）。

付款方式

普票匯款信息

賬戶(hù) 名：上海生物

開(kāi) 戶(hù) 行：中國(guó)銀行山東省分行營(yíng)業(yè)部

賬號(hào)：2169 2341 6278

為方便廣大客戶(hù)辦理貨款我公司提供多個(gè)銀行的賬戶(hù)，學(xué)校、醫(yī)院客戶(hù)購(gòu)買(mǎi)產(chǎn)品如因單位財(cái)務(wù)制度原因可先發(fā)貨待報(bào)賬后匯款，請(qǐng)及時(shí)告知銷(xiāo)售人員已做具體操作。